Auteurs
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Hideko Nakahara »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hideko Kozuru < Hideko Nakahara < Hidemichi Kouzu  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
001571 (2013) Mie Fusama [Japon] ; Hideko Nakahara ; Yoshimasa Hamano ; Masayuki Nishide ; Keisuke Kawamoto ; Takashi Hosokawa ; Satoko Nozato ; Shinji Higa ; Tsuyoshi Igarashi ; Eiji Takeuchi ; Takanori Kuroiwa ; Yasunori Shimaoka ; Masao Yukioka ; Yasushi Miura ; Kayoko Higashi ; Taro Kuritani ; Keiji MaedaImprovement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumab.
001952 (2011) Hideko Nakahara [Japon] ; Yosuke Kamide ; Yoshimasa Hamano ; Takashi Hosokawa ; Masayuki Nishide ; Yu Lin ; Keisuke Kawamoto ; Mie Fusama ; Shinji Higa ; Takashi Kuroiwa ; Tsuyoshi Igarashi ; Taro Kuritani ; Keiji MaedaA case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment.
001B19 (2009) Hideko Nakahara [Japon] ; Toru Mima ; Naoko Yoshio-Hoshino ; Masato Matsushita ; Jun Hashimoto ; Norihiro NishimotoA case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years.
001B43 (2008) Norihiro Nishimoto [Japon] ; Hideko Nakahara ; Naoko Yoshio-Hoshino ; Toru MimaSuccessful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody.
001B45 (2008) Norihiro Nishimoto [Japon] ; Kimio Terao ; Toru Mima ; Hideko Nakahara ; Nobuhiro Takagi ; Takahiro KakehiMechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease.
001C16 (2006) Hideko Nakahara [Japon] ; Norihiro NishimotoAnti-interleukin-6 receptor antibody therapy in rheumatic diseases.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Hideko Nakahara" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Hideko Nakahara" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Hideko Nakahara
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021